Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Collier

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Open Forum Infectious Diseases|April 6, 2019
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV ClassificationCharlotte Hedskog, Bandita Parhy, Silvia Chang, et al.
Hepatology (Baltimore, Md.)|September 16, 2016
Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E VirusAnthony Brown, John S Halliday, Leo Swadling, et al.
Mbio|June 27, 2019
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus InfectionLouise O Downs, David A Smith, Sheila F Lumley, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Plos One|January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virusAminata Sy, Leanne McCabe, Emma Hudson, et al.
Vaccines|August 5, 2016
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic InfectionLeo Swadling, John Halliday, Christabel Kelly, et al.
Hepatology (Baltimore, Md.)|February 24, 2018
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialGraham R Foster, Kosh Agarwal, Matthew E Cramp, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humansChristabel Kelly, Leo Swadling, Stefania Capone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Open Forum Infectious Diseases|April 6, 2019
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV ClassificationCharlotte Hedskog, Bandita Parhy, Silvia Chang, et al.
Hepatology (Baltimore, Md.)|September 16, 2016
Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E VirusAnthony Brown, John S Halliday, Leo Swadling, et al.
Mbio|June 27, 2019
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus InfectionLouise O Downs, David A Smith, Sheila F Lumley, et al.
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Plos One|January 23, 2023
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virusAminata Sy, Leanne McCabe, Emma Hudson, et al.
Vaccines|August 5, 2016
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic InfectionLeo Swadling, John Halliday, Christabel Kelly, et al.
Hepatology (Baltimore, Md.)|February 24, 2018
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialGraham R Foster, Kosh Agarwal, Matthew E Cramp, et al.
Hepatology (Baltimore, Md.)|October 17, 2015
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humansChristabel Kelly, Leo Swadling, Stefania Capone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Pageof 5